Table 1.

The univariate and multivariate analyses assessing the relation between clinical, radiological, laboratory features and F2-IsoP levels regarding DCI occurrence.

	Total n = 27	DCI n = 13 (48.1%)	Without DCI n = 14 (51.9%)	Univariate OR (95% CI)	P value	Multivariate OR (95% CI)	P value
Age (years)	61 (50–66)	63 (61–70)	54 (43–61)	1.05 (0.99–1.12)	0.099
Sex (male)	11 (41%)	6 (46%)	5 (36%)	1.53 (0.32–7.22)	0.582
Location (anterior circulation)	24 (89%)	13 (100%)	11 (79%)	N.A	1.000
Treatment (surgical treatment)	24 (89%)	13 (100%)	11 (79%)	N.A	1.000
Hunt and Hess scale
I	1 (4%)	0 (0%)	1 (7.1%)	1.73 (0.47–6.4)	0.405
II	8 (30%)	3 (23%)	5 (35.8%)
III	17 (63%)	10 (77%)	7 (50%)
IV	1 (4%)	0 (0%)	1 (7.1%)
mFisher grade
I	3 (11%)	0 (0%)	3 (21.5%)	3.57 (1.14–11.13)	0.028
II	4 (15%)	0 (0%)	4 (28.5%)
III	4 (15%)	3 (23%)	1 (7.2%)
IV	16 (59%)	10 (77%)	6 (42.8%)
Intracerebral haemorrhage (ICH)	5 (18.5%)	2 (15.4%)	3 (21.4%)	0.66 (0.09–4.8)	0.687
Hydrocephalus (HCP)	14 (51.8%)	8 (61.5%)	6 (42.8%)	2.13 (0.45–9.94)	0.334
Anisocytosis parameters
RDW-CV (%CV)—day 1	13.8 ± 1.5 13 (12–15)	14.5 ± 1.8 14 (13–15)	13.2 ± 0.9 13(12–13)	1.92 (1.02–3.61)	0.042	1.289 (1.041–1.597)	0.020
RDW-SD (fl)—day 1	43.5 ± 8.9 42 (39–50)	47.2 ± 10 49 (44–53)	40.1 ± 6 40 (38–42)	1.11 (1–1.23)	0.049
RDW-CV (%CV)—day 3	12.5 ± 0.8 12 (11–13)	12.6 ± 0.9 12 (11–13)	12.4 ± 0.8 12 (11–12)	1.32 (0.55–3.16)	0.525
RDW-SD (fl)—day 3	42.1 ± 4.5 42 (39–44)	41.6 ± 6 40 (38–44)	42.5 ± 2.5 43(40–44)	0.95 (0.8–1.13)	0.581
RDW-CV (%CV)—day 5	12.9 ± 0.9 12 (12–13)	12.8 ± 1 12 (11–13)	12.9 ± 0.8 13 (12–13)	0.84 (0.36–1.94)	0.690
RDW-SD (fl)—day 5	41.7 ± 4 40 (39–44)	41.5 ± 4 40 (38–43)	41.9 ± 3.6 42 (39–44)	0.97 (0.8–1.17)	0.774
ISOP CSF conc
Day 1 (pg/ml)	43.9 ± 42 25 (16–67)	65.7 ± 50 67 (23–83)	23.7 ± 19 20 (7–28)	1.04 (1–1.08)	0.028	1.094 (1.005–1.191)	0.039
Day 3 (pg/ml)	49.3 ± 37 43 (16–80)	65.8 ± 39 76 (21–94)	36.4 ± 30 22 (12–59)	1 (0.98–1)	0.878
Day 5 (pg/ml)	46 ± 32 43 (22–53)	61.7 ± 52 (43–76)	31.4 ± 17 34 (16–43)	1.05 (1.004–1.097)	0.031